bibliographicCitation |
Gordon P, Thomas JA, Suter R, Jurecki E. Evolving patient selection and clinical benefit criteria for sapropterin dihydrochloride (Kuvan®) treatment of PKU patients. Molecular Genetics and Metabolism. 2012 Apr;105(4):672–6. doi: 10.1016/j.ymgme.2011.12.023. |